...
首页> 外文期刊>AIDS and behavior >Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men
【24h】

Associations Between Major Depressive Episode, Methamphetamine Use Disorder Severity, and Engagement in Sexual Risk-Taking Among Methamphetamine-Using Men Who Have Sex with Men

机译:主要抑郁发作,甲基苯丙胺使用障碍严重程度的关联,以及与男性发生性发生性发生性关系的人的甲基苯丙胺类中的性风险

获取原文
获取原文并翻译 | 示例
           

摘要

Depression and methamphetamine use have been associated with increased sexual risk-taking among men who have sex with men (MSM). This study estimated associations between current major depressive episode and/or methamphetamine use disorder and engagement in condomless anal intercourse (CAI). From March 2014 thru January 2016, 286 methamphetamine-using MSM were enrolled into a RCT to reduce methamphetamine use and sexual risk-taking. Analyses revealed that current major depressive episode was associated with a 92% increase in the rate of engagement in CAI with casual male partners (IRR 1.92; 95% CI 1.12-3.31) and a 76% increase in the rate of engagement in CAI with anonymous male partners (IRR 1.76; 95% CI 1.00-3.09). Additionally, for each unit increase in diagnostic methamphetamine use disorder severity, rates of engagement in CAI with anonymous male partners increased by 44% (IRR 1.44; 95% CI 1.11-1.87) and rates of engagement in CAI with exchange male partners increased by 140% (IRR 2.40; 95% CI 1.39-4.13). Neither diagnosis was associated with CAI with main male partners. Depression and methamphetamine use influence sexual risk-taking in unique ways, and interventions working with MSM should assess participants for both depression and methamphetamine use, and may tailor intervention content based on diagnostic outcomes.
机译:抑郁症和甲基苯丙胺用途与随着男性发生性关系的男性(MSM)增加了性风险增加。本研究估计当前主要抑郁发作和/或甲基苯丙胺使用障碍与静止肛交(CAI)的参与之间的关联。从2014年3月到2016年1月,286甲基苯丙胺使用MSM被纳入RCT,以降低甲基苯丙胺使用和性风险。分析表明,目前的主要抑郁发作与休闲男性合作伙伴(FRIT 1.92; 95%CI 1.12-3.31)的CAI接合速度提高92%有关,并匿名参与率为76%男性合作伙伴(FRIR 1.76; 95%CI 1.00-3.09)。此外,对于每个单位的诊断甲基苯丙胺使用障碍严重程度,CAI与匿名男性合作伙伴的CAI率增加了44%(FRIS 1.44; 95%CI 1.11-1.87)和交换男性合作伙伴的CAI的参与率增加140 %(IRR 2.40; 95%CI 1.39-4.13)。诊断既不与主要男性合作伙伴都与CAI相关联。抑郁和甲基苯丙胺使用影响性风险以独特的方式采取性风险,与MSM合作的干预措施应评估抑郁症和甲基苯丙胺的参与者,并可根据诊断结果定制干预含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号